We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 29th:
EVERTEC, Inc. (EVTC - Free Report) : This transaction processing company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings surging 19.7% over the last 60 days.
IRadimed Corporation (IRMD - Free Report) : This distributor of MRI compatible medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 20% over the last 60 days.
Delphi Technologies PLC : This designer of integrated powertrain technologies has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.8% over the last 60 days.
ResMed Inc. (RMD - Free Report) : This manufacturer of medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 5.7% over the last 60 days.
<img src="https://staticx-tuner.zacks.com/images/charts/af/1527597900.png" width="538" height="250" alt="ResMed Inc. Price" title="" />
</a>
<p><a href="https://www.zacks.com/stock/chart/RMD/price?icid=chart-RMD-fundamental/price">ResMed Inc. price</a> | <a href="https://www.zacks.com/stock/quote/RMD?icid=chart-RMD-fundamental/price">ResMed Inc. Quote</a></p>
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for May 29th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 29th:
EVERTEC, Inc. (EVTC - Free Report) : This transaction processing company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings surging 19.7% over the last 60 days.
Evertec, Inc. Price and Consensus
Evertec, Inc. price-consensus-chart | Evertec, Inc. Quote
EVERTEC’s shares gained 18.9% over the last one month higher than the S&P 500’s increase of 2.8%. The company possesses a Momentum Score of B.
Evertec, Inc. Price
Evertec, Inc. price | Evertec, Inc. Quote
IRadimed Corporation (IRMD - Free Report) : This distributor of MRI compatible medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 20% over the last 60 days.
iRadimed Corporation Price and Consensus
iRadimed Corporation price-consensus-chart | iRadimed Corporation Quote
IRadimed’s shares gained 5.7% over the last one month. The company possesses a Momentum Score of A.
iRadimed Corporation Price
iRadimed Corporation price | iRadimed Corporation Quote
Delphi Technologies PLC : This designer of integrated powertrain technologies has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 3.8% over the last 60 days.
Delphi Technologies PLC Price and Consensus
Delphi Technologies PLC price-consensus-chart | Delphi Technologies PLC Quote
Delphi Technologies’ shares gained 5.7% over the last one month. The company possesses a Momentum Score of A.
Delphi Technologies PLC Price
Delphi Technologies PLC price | Delphi Technologies PLC Quote
ResMed Inc. (RMD - Free Report) : This manufacturer of medical devices has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings advancing 5.7% over the last 60 days.
ResMed Inc. Price and Consensus
ResMed Inc. price-consensus-chart | ResMed Inc. Quote
ResMed’s shares gained 9% over the last one month. The company possesses a Momentum Score of A.
ResMed Inc. Price
ResMed Inc. price | ResMed Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>